• Corpus ID: 6613546

Endocrinopathies in beta-thalassemia major. Prevalence, risk factors, and age at diagnosis in Northwest Saudi Arabia.

@article{Habeb2013EndocrinopathiesIB,
  title={Endocrinopathies in beta-thalassemia major. Prevalence, risk factors, and age at diagnosis in Northwest Saudi Arabia.},
  author={Abdelhadi Habeb and Zakaria M. Al-Hawsawi and Mohamed M. Morsy and Abdallah M Al-Harbi and Adnan S Osilan and Mohamed Sf Al-Magamsi and Mohamed A Zolaly},
  journal={Saudi medical journal},
  year={2013},
  volume={34 1},
  pages={
          67-73
        }
}
OBJECTIVE To define the prevalence, risk factors, and age at diagnosis of endocrinopathies in beta-thalassemia major (BTM) in Northwest Saudi Arabia. METHODS This retrospective cross-sectional study included patients with BTM attending a combined endocrine-hematology clinic in Al-Madinah, Kingdom of Saudi Arabia from March 2009 to December 2010. Clinical and biochemical data from the initial clinic visits were used to define the prevalence and age of diagnosis of endocrinopathies. Demographic… 

Figures and Tables from this paper

Endocrinopathies in Turkish Children with Beta Thalassemia Major: Results from a Single Center Study

TLDR
Beta thalassemia major, having the potential of leading to multisystemic complications, is a chronic disease that should be treated and followed-up by a multidisciplinary approach.

Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran

TLDR
Age, body mass index and splenectomy were significantly associated with most of the endocrine disorders andperiodic surveillance of endocrine function and proper management of iron overload are advised.

Complications of Transfusion-Dependent β-Thalassemia Patients in Sistan and Baluchistan, South-East of Iran

TLDR
As cardiac events are significantly more common among TDT patients, close monitoring of the heart function is recommended for identifying patients with cardiac problems, as cardiac complications were the most frequent sequela in patients >15 years old.

Biochemical Status of Beta-Thalassemia Major Patients in Erbil City

TLDR
This study demonstrates that in B-thalassemia major patients Serum Ferritin and Iron were increased proportionally with increasing age and number of units of blood transfusion.

Prevalence of Sickle Cell Anemia and Thalassemia among Anemic Patients of Al-Noor Specialist Hospital, Makkah, KSA

TLDR
It was found a significant increase in the prevalence of Sickle cell diseases and trait and high hemoglobin (Hb) A2 βthalassemia among patients of Al-Noor Specialist hospital, Makkah between 1 January 2012 and 30 December 2012.

Prevalence of hypoparathyroidism, growth retardation in patients of Beta-thalassemia major

TLDR
Significant Hypoparathyroidism (HPT) observed along with growth retardation in beta thalassemia patients (p < 0.001) was seen in cases when compared to controls, where as the levels of both serum phosphorus and alkaline phosphatase levels were found increased in cases as compared to control.

Evaluation of gonadal function in transfusion-dependent β-thalassemia patients of Bangladesh

TLDR
G gonadal hormone analysis of transfusion-dependent thalassemia patients can be considered a screening tool for assessing gonadal function and early detection and prevention of hypogonadism.

Depression, Anxiety, and Stress Symptoms in Patients With Beta Thalassemia Major in Almadinah Almunawwarah, Saudi Arabia

TLDR
BTM patients are prone to develop psychological disorders, which can affect the course of the disease, and results are comparable to international and Arab population studies, which have the highest reported prevalence.

The effect of deferasirox on endocrine complications in children with thalassemia

TLDR
It was determined that both existing endocrine abnormalities were reduced and recent developed problems were less likely with long-term deferasirox treatment in thalassemia patients.

References

SHOWING 1-10 OF 37 REFERENCES

Prevalence of endocrinopathies in patients with Beta-thalassaemia major - a cross-sectional study in oman.

TLDR
There is high prevalence of endocrine disorders among Omani beta-thalassaemic adult patients and the importance of awareness for their development and monitoring for early detection and replacement therapy is marked.

Failure of puberty in Egyptian beta thalassemic patients: Experience in north east region—Dakahlia province

TLDR
It is concluded that failure of puberty is common in thalassemic patients which necessitates newer protocols of treatment, correct blood transfusion and chelation therapy.

Hypocalcemia due to hypoparathyroidism in beta-thalassemia major patients.

TLDR
HPT due to iron overload may develop in a significant number of thalassemia major patients, especially when chelation therapy is not optimal, therefore, all thalasamics should be carefully watched for this complication from early in their second decade.

Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran

TLDR
High prevalence of complications among thalassemics signifies the importance of more detailed studies along with therapeutic interventions, and shows significant association with lumbar but not femoral BMD.

Assessment of Thyroid Function in Two Hundred Patients with β-Thalassemia Major

TLDR
The prevalence of thyroid dysfunction in a large homogenous group of thalassemic patients with β-thalassemia major was estimated by randomly selecting patients from a pool of approximately 800 patients followed in the authors' department.

Assessment of thyroid function in two hundred patients with beta-thalassemia major.

TLDR
Thyroid failure is a rather rare endocrine complication in patients with beta-thalassemic from Greece, and no case of central hypothyroidism was observed, indicating no correlation between ferritin levels and thyroid functional status.

Mild subclinical hypothyroidism in thalassaemia major: prevalence, multigated radionuclide test, clinical and laboratory long-term follow-up study.

TLDR
From 1990 to 1991, the Pediatric and Adolescent Endocrine Outpatient Clinic of Arcispedale S. Anna admitted 97 thalassaemia major (TM) patients for endocrine evaluation, and patients with SH exhibited three different thyroid function patterns during follow-up, which show a high prevalence of primary hypothyroidism with the predominance of its predominant form.

Premarital screening for thalassemia and sickle cell disease in Saudi Arabia

TLDR
The program's objective of decreasing high-risk marriages was not as successful, indicating the need for improvement of health education programs for the public, more efforts in counseling high risk couples, and changes in the strategy of timing of screening in relation to marriage.

Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.

TLDR
The longitudinal study shows that in the last 30 years in the Ferrara Centre the incidences of hypothyroidism, diabetes mellitus, and hypoparathyroidism declined, and pubertal development in males with thalassemia major improved in patients, on DFO treatment, born after 1976.

Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.

TLDR
The need for vigilant follow-up of patients with thalassemia in order to treat endocrine dysfunction at an appropriate age is supported, and a low serum level of gonadotropins in over 14-year-old patients with impaired puberty is found, which indicated that hypog onadotropic hypogonadism is responsible for this complication.